Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
PIN Pharma logo — A pioneering biopharmaceutical firm dedicated to creating br...

PIN Pharma

A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems.

Founded 2011 Series A Total: $6.75M Biotechnology, Pharmaceutical

General Information

Company Name PIN Pharma
Founded Year 2011
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when PIN Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PIN Pharma

PIN Pharma is a pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems. Established in 2011, the company is a venture-backed research and development entity specialized in immunotherapies, with a primary focus on oncology. However, its technology holds promise for applications in various other disease areas. The latest significant funding for PIN Pharma was a $6.75M Series A investment in January 2014, led by NGN Capital. The firm's innovative method for linking the innate and adaptive immune systems is at the core of its dedication to developing ground-breaking therapies with broader applications throughout the field of biotechnology and pharmaceuticals.

Taxonomy: biopharmaceutical, immunotherapy, oncology, innovative technology, venture-backed, immune system modulation, therapeutic applications, private company, biomedical research, immunomodulation, cancer treatment, immune response, therapeutic innovation, disease areas

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
01 Jan 2014

PIN Pharma Alternatives & Competitors

PIN Pharma vs
Etcembly Ltd
Etcembly Ltd United Kingdom

TCRs by intelligent design

35 employees
Biotechnology, Machine Learning
PIN Pharma vs
Tridek-One
Tridek-One France

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

Series Unknown
12 employees
Biotechnology, Health Care
PIN Pharma vs
IsoPlexis
IsoPlexis United States

Powerful Biology Accelerating the Future of Medicine

Series D
65 employees
Biotechnology, Health Care

FAQ About PIN Pharma

A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems.
PIN Pharma was founded in 2011.
PIN Pharma operates in the following industries: Biotechnology, Pharmaceutical.
PIN Pharma has completed 1 funding round, raising a total of $6.75M. The latest funding stage is Series A.
Top alternatives and competitors to PIN Pharma include Etcembly Ltd, Tridek-One, IsoPlexis, Zura Bio Limited (Nasdaq: ZURA), RemedyBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PIN Pharma and Etcembly Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PIN Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy